Pregnolia

company

About

Pregnolia developed an innovative system to accurately assess the stiffness of the cervical tissue of pregnant and non-pregnant women.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
Fr4.20M
Industries
Intelligent Systems,Medical Device
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete the clinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
Fr12.45M
Pregnolia has raised a total of Fr12.45M in funding over 2 rounds. Their latest funding was raised on Jun 25, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 25, 2020 Series A Fr4.20M 1 Detail
Apr 24, 2020 Series A Fr5M 1 Detail
Feb 14, 2018 Seed Fr3.25M 1 Verve Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Pregnolia is funded by 2 investors. Verve Ventures and SwissHealth Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Verve Ventures Series A
SwissHealth Ventures Series A